- Investing Ideas
- /
- Belgian Large Cap High Growth Potential
Belgian Large Cap High Growth Potential
Results
5
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
5 companies
argenx
Market Cap: €35.2b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€575.80
7D
-3.1%
1Y
23.1%
D'Ieteren Group
Market Cap: €9.6b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€181.30
7D
4.3%
1Y
-10.3%
Elia Group
Market Cap: €11.0b
Develops and operates as a transmission system operator in Belgium and Germany.
ELI
€100.70
7D
-0.5%
1Y
4.1%
Groupe Bruxelles Lambert
Market Cap: €9.1b
Invests in a portfolio of industrial, consumer goods, and business service companies operating in various sectors in Belgium, other European countries, North America, and internationally.
GBLB
€74.15
7D
0.7%
1Y
13.0%
UCB
Market Cap: €35.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€184.50
7D
-3.1%
1Y
18.2%